SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: jaybe who wrote (4285)5/26/2016 10:22:04 PM
From: glass 0.5 full  Respond to of 4474
 
Wonder why they're excluding patients with spinal cord compression -- given that lung cancer tumors are a predictable (if not common) cause, those are some patients who would have some interest.



To: jaybe who wrote (4285)5/27/2016 12:31:53 AM
From: Zohar_Power  Respond to of 4474
 
Very good news, that the patients in need can now get access to brigatinib, even if they are not on the clinical trial.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News